RHB Retail Research
Technical Analysis - CCM Duopharma Biotech
CCM Duopharma Biotech may rebound higher after it continued holding above the MYR1.18 support. As the stock rose above the 21-day SMA line, this indicates a positive sign. A bullish bias may appear above the MYR1.21 level, with an exit set below the MYR1.18 threshold. Towards the upside, the near-term resistance is at MYR1.30. This is followed by the MYR1.35 level.
Source: RHB Securities Research - 27 Aug 2018
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
More articles on RHB Retail Research
Duopharma Biotech - Lacking Near-Term Re-Rating Catalysts; D/G NEUTRAL
Created by rhboskres | Aug 26, 2024
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
MQ Trading Signals
Time
Signal
Duration
Type
2024-11-26 16:45:00
EMA 5
5 Mins
BUY
2024-11-26 16:40:00
EMA 5
10 Mins
BUY
2024-11-26 16:40:00
ADX
5 Mins
BUY
2024-11-26 16:40:00
VOLUME BREAKOUT
5 Mins
BUY
2024-11-26 16:10:00
EMA 5
10 Mins
SELL
Apps
Top Articles
1
2
THE INVESTMENT APPROACH OF CALVIN TAN
3
4
save malaysia!
5
Koon Yew Yin's Blog
7
8
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
